As a Partner at Boult I work with a range of clients including individual inventors, new start-ups as well as commercial-stage companies.
I have a PhD in metabolism and diabetes, although my practice focuses on a variety of biotechnology disciplines including antibody therapeutics, regenerative medicine, cell culture methods, cancer diagnostics, biomarkers, and targeted protein degradation.
I am able to guide clients through all stages of the patent process and have experience in drafting and prosecution, managing global patent portfolios, patent filing strategies for example to protect pre-clinical and clinical stage biologics, competitor monitoring, freedom-to-operate, opposition and appeal proceedings before the EPO, and infringement and validity assessments. I am also proficient in the filing of Supplementary Protection Certificates (SPCs) and paediatric extensions.
I have a particular interest in the interplay between IP rights and regulatory exclusivity, so I can provide practical advice for my clients that are navigating marketing authorisations, regulatory requirements, loss of exclusivity and biosimilar entry. This requires that I stay on top of changes in relevant government policy and pharmaceutical legislation both in the UK and Europe.
I remain engaged in other aspects of the life sciences industry having previously assisted as an editor for an online science and technology journal. I also write articles regularly on key topics of interest.
Boult was always my first choice of firm, and I joined here initially as a patent trainee. We hire individuals with strong academic backgrounds and place a real emphasis on high quality training. There is a wealth of talent here.





